Evidence map›Paper›PMID 36046749›Full record

ArticleSarcoma2022

Adjuvant Radiation after Primary Resection of Atypical Lipomatous Tumors of the Extremity Reduces Local Recurrence but Increases Complications: A Multicenter Evaluation.

Joshua M Lawrenz, Samuel R Johnson, Kevin Zhu, Mallory McKeon, Cullen P Moran, Jose Vega, Katherine S Hajdu, James P Norris, Leo Y Luo, Eric T Shinohara and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Sarcoma, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Joshua M LawrenzDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville 37232, TN, USA.ORCID https://orcid.org/0000-0003-4069-7044
Samuel R JohnsonDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
Kevin ZhuDepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland 44195, OH, USA.
Mallory McKeonDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
Cullen P MoranDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
Jose VegaDepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland 44195, OH, USA.
Katherine S HajduDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
James P NorrisDepartment of Orthopaedic Surgery, Spartanburg Regional Healthcare System, Spartanburg 29307, SC, USA.
Leo Y LuoDepartment of Radiation Oncology, Vanderbilt University Medical Center, Nashville 37232, TN, USA.ORCID https://orcid.org/0000-0002-3061-4287
Eric T ShinoharaDepartment of Radiation Oncology, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
Justin M M CatesDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville 37232, TN, USA.ORCID https://orcid.org/0000-0002-7336-5196
Brian P RubinDepartment of Pathology, Cleveland Clinic, Cleveland 44195, OH, USA.ORCID https://orcid.org/0000-0002-0657-3024
John D ReithDepartment of Pathology, Cleveland Clinic, Cleveland 44195, OH, USA.
Jennifer L HalpernDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
Nathan W MeskoDepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland 44195, OH, USA.ORCID https://orcid.org/0000-0001-7331-5618
Herbert S SchwartzDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
Lukas M NystromDepartment of Orthopaedic Surgery, Cleveland Clinic, Cleveland 44195, OH, USA.ORCID https://orcid.org/0000-0001-8120-2680
Ginger E HoltDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville 37232, TN, USA.
Vanderbilt University Medical Center · USCleveland Clinic · USSpartanburg Regional Healthcare System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Radiation after resection of an atypical lipomatous tumor (ALT) is controversial. This study evaluates local control and complications after the first resection of ALTs of the extremity with or without adjuvant radiation. Methods: A dual institution, retrospective review of patients treated from 1995 to 2020 with first-time resection of an ALT in the extremity was performed. In total, 102 patients underwent adjuvant radiation (XRT group) and 68 patients were treated with surgery alone (no-XRT group). The median follow-up time was 4.6 years (interquartile range (IQR) 2.0-7.3 years). The median radiation dose was 60 Gy (IQR 55-66 Gy). Univariable and multivariable analyses evaluated the association of patient, tumor, and treatment variables with recurrence and complications. Kaplan-Meier analysis evaluated local recurrence-free survival (LRFS) and time to complication. Results: The overall incidence of local recurrence was 1% (1/102) in the XRT group and 24% (16/68) in the no-XRT group ( Conclusions: Adjuvant radiation after first-time resection of an ALT of the extremity was associated with a significantly reduced risk of local recurrence but a three-fold increase in complication rate. These data support a 10-year follow-up for these patients and inform a notable clinical trade-off if considering adjuvant radiation for this tumor with recurrent potential.

Identifiers

PMID36046749
PMCPMC9424010
OpenAlexW4292673970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.